This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

KEYTRUDA® (pembrolizumab)

KeyFocus Prof Winald Gerritsen full webcast: The role of immunotherapy in Advanced Urothelial Carcinoma

Placeholder img
Prescribing Information

Length: 25:45

Full presentation KEYFOCUS Bladder Cancer 2018: Professor Winald Gerritsen discusses the role of immunotherapies and how they are shaping the advanced urothelial carcinoma treatment paradigm.

More information about KEYTRUDA® (pembrolizumab):

GB-PDO-00368 | Date of Preparation: April 2019